Skip to content

Author

Kevin Schutz

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Abstract A020: Engineering developability of anti-CD3 scFv-based multispecific T-cell engagers

Stabilized anti-CD3 scFv not only improve properties of two clinical CD20 Fab-based multispecifics but rescue assembly of a third clinical CD20 molecule, which did not produce with the parental, unmodified scFv or with the industry standard engineered disulfide bond VH44-VK100.

Rob Pejchal, Kevin Schutz, Michael B. Battles et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.